glp 1 action mechanism Frontiers GLP1-GIP receptor co-agonists: a promising
Description
Glucose-dependent insulinotropic polypeptide reduces fat-specific expression and activity of 11beta-hydroxysteroid dehydrogenase type 1 and inhibits release of free fatty acids
Understanding GLP-1 Medications GLP-1 medications (glucagon-like peptide-1 receptor agonists) are remarkable tools for managing diabetes and weight loss
Most PBMs have announced partnerships with one or more vendors, recognizing that combining medication with behavioral support can improve outcomes
Adults on GLP-1 receptor agonists for extended periods show reduced risk of cognitive decline and dementia in several observational and trial datasets, with effect sizes ranging from modest single-digit reductions to much larger ones, depending on the cohort
Thazhath SS, et al
2023 ESC Guidelines for the Management of Cardiovascular Disease in Patients with Diabetes
